Accéder au contenu
Merck

MiR-18a regulates myoblasts proliferation by targeting Fgf1.

PloS one (2018-08-01)
Chuncheng Liu, Min Chen, Meng Wang, Wenhui Pi, Ning Li, Qingyong Meng
RÉSUMÉ

MiRNAs play an important role in cell proliferation, apoptosis, and differentiation. MiR-18a is increasingly being recognized as a regulator of cancer pathogenesis. Here, we discovered that miR-18a participates in myoblasts proliferation. Expression of miR-18a was downregulated with the differentiation of C2C12 myoblasts. Overexpression of miR-18a affected the proliferation of C2C12 cells, primary myoblasts and RD cells. MiR-18a influenced the expression of cell cycle-related genes. Using TargetScan 6.2, we found that the 3' untranslated region (UTR) of the mouse Fgf1 gene contains complementary sequences to miR-18a. Using a siRNA, we confirmed that the reduction in the Fgf1 levels inhibited proliferation of C2C12 cells. Therefore, our results show that miR-18a participates in the regulation of proliferation by partly decreasing the expression of Fgf1.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Roche
Cocktails d′inhibiteurs de protéases cOmplete ULTRA, sans EDTA, pastilles EASYpack, Tablets supplied in foil blister packs.
Sigma-Aldrich
Monoclonal Anti-BrdU antibody produced in mouse, clone BU-33, ascites fluid, Immunohistology Grade
Sigma-Aldrich
Methyl 2,4-dibromobutyrate, ≥97.0% (GC)